Skip to content

    Zen Technologies

    ZENTECGood
    Capital Goods·19 May 2025
    Management Summary

    Zen Technologies reported a record year driven by strong execution in exports and a pivot toward high-margin anti-drone systems. While management warned of a 'muted' FY26 due to order timing and execution spillovers, they remain extremely bullish on the medium term, targeting ₹6,000+ crores in cumulative revenue over the next three years. The company is leveraging its massive ₹1,037 crore cash pile for both organic R&D and inorganic acquisitions to dominate the 'design-developed-and-made-in-India' (IDDM) defense category.

    Highlights

    7
    • Standalone order book stands at ₹692 crores, with consolidated order book estimated at over ₹792 crores.

    • Total cash balance reached ₹1,037 crores, comprising ₹410 crores from QIP and ₹625 crores from internal accruals.

    • Cash conversion cycle significantly improved to 160 days as of March 31, 2025, down from 237 days in the previous quarter.

    • Export execution for the year totaled approximately ₹300 crores, targeting Africa, CIS, and Middle East markets.

    • Management set an aggressive cumulative turnover target of over ₹6,000 crores for the FY26-FY28 period.

    • Maintained margin guidance of 35% EBITDA and 25% PAT (excluding interest income from QIP proceeds).

    • Subsidiary performance: ARIPL reported ₹137 crores in revenue for FY25; UTS contributed ₹125-130 crores.

    Concerns

    1
    • Chinese Software/Hardware Vulnerabilities

    What Changed1

    vs Q2 FY26

    Guidance items4 → 5 (+1)

    Key financials

    Single quarter

    06 metrics
    1. 01Standalone Order Book₹692 Cr
    2. 02Total Cash Balance₹1,037 Cr
    3. 03Cash Conversion Cycle160 days-32.5%QoQ
    4. 04Annual Export Revenue₹300 Cr
    5. 05EBITDA Margin Guidance35%

    Segment breakdown

    • ARIPL (Subsidiary)₹137 Cr51.8%
    • UTS (Subsidiary)₹127.5 Cr48.2%
    Donut· Share of Annual Revenue

    Guidance & targets

    5
    CategoryTargetPriority
    Other
    Order Inflow
    ₹800 crores
    High
    Other
    Working Capital Cycle
    135-140 days
    Medium
    Revenue
    Cumulative Turnover
    ₹6,000+ crores
    High
    Margin
    EBITDA Margin
    35%
    High
    Capex
    R&D Facility Expenditure
    ₹70 crores
    High

    Risks & concerns

    4
    RiskSeverity

    Execution Delay / Muted FY26

    Management explicitly stated FY26 revenue may be muted because order execution will likely spill into FY27.Management acknowledged

    medium

    Chinese Software/Hardware Vulnerabilities

    CMD highlighted significant security risks from Chinese-made solar panels, EVs, and electronics that can be remotely deactivated.Management acknowledged

    high

    Export Order Visibility

    Analysts questioned the 'dried up' export order book; management countered that conversations have shifted to higher-end band-independent systems post-recent crises.Analyst downplayed

    medium

    Areas of Evasion(1)

    • Specific details on which countries (e.g., Armenia) are placing orders due to non-disclosure agreements.

    Q&A highlights

    3

    “Even if lot of orders come the execution will spill into the next financial year so that is the reason we are saying that this year will be muted.”

    Explains the disconnect between a strong order pipeline and a conservative near-term revenue outlook due to execution timelines.

    asked by Garvit Goyal

    2 min read5 chapters

    Detailed Narrative

    01

    Anti-Drone Systems: From R&D to War-Tested Reality

    Zen Technologies' strategic bet on anti-drone systems, initiated in 2018, has reached a critical inflection point following 'Operation Sindoor.' The company's systems are now 'war-tested,' providing a significant marketing advantage. Management claims to be the only private sector company to qualify under the Indian Armed Forces' IDDM (Indigenously Designed, Developed and Manufactured) category for these systems. The market opportunity for anti-drone projects is now estimated to be significantly higher than the previous ₹10,000 crore estimate, driven by a shift toward autonomous 'hard kill' solutions.

    02

    Strategic Revenue Mix Shift

    The company is undergoing a fundamental shift in its business model. While historically a simulation and training company, Zen expects anti-drone, drone, and 'hard kill' options to constitute 70% of the business within five years. The remaining 30% will be sustained by its traditional training and simulation segments. This shift is expected to support high margins, with management maintaining a long-term guidance of 35% EBITDA and 25% PAT.

    03

    Working Capital and Cash Management

    Zen has demonstrated significant operational efficiency by reducing its cash conversion cycle from 237 days to 160 days in a single quarter. The CFO targets a further reduction to 135-140 days in FY26. With a massive cash pile of ₹1,037 crores, the company is well-positioned for inorganic growth. Management confirmed they are actively 'working on' further acquisitions to complement their existing portfolio of UTS, ARI, and Vector Technics.

    04

    The FY26 'Muted' Outlook vs. Long-term Aggression

    Management provided a nuanced outlook for FY26, describing it as 'muted' due to the timing of order receipts and the long lead times for defense execution. However, this is framed as a temporary phase before a massive scale-up. The company is targeting ₹800 crores in new orders by H1 FY26 and a cumulative turnover exceeding ₹6,000 crores over the FY26-FY28 period, implying a steep growth trajectory in the latter two years.

    05

    Global Expansion and US Market Entry

    Zen is aggressively pursuing international markets, with a focus on the US and Europe. The company has deployed senior resources in the US and expects significant order flow from that region by FY2027. In Europe, Zen is positioning itself to benefit from a potential 'defense super cycle' and NATO-related procurement, leveraging its world-class simulator and anti-drone technology to secure free trade opportunities.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.